Lexicon Pharmaceuticals, Inc. - Current Ratio

The Current Ratio as of June 2026 (TTM) for Lexicon Pharmaceuticals, Inc. (LXRX) is 18.79

According to Lexicon Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 18.79. This represents a change of 124.52% compared to the average of 8.37 of the last 4 quarters.

Lexicon Pharmaceuticals, Inc. (LXRX) Historical Current Ratio (quarterly & annually)

How has LXRX Current Ratio performed in the past?

The mean historical Current Ratio of Lexicon Pharmaceuticals, Inc. over the last ten years is 4.40. The current 18.79 Current Ratio has changed 42.58% with respect to the historical average. Over the past ten years (40 quarters), LXRX's Current Ratio was at its highest in in the March 2026 quarter at 18.79. The Current Ratio was at its lowest in in the September 2020 quarter at 1.55.

Lexicon Pharmaceuticals, Inc. (LXRX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Lexicon Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lexicon Pharmaceuticals, Inc. (LXRX) Average Current Ratio

How has LXRX Current Ratio performed in the past?

The current Current Ratio of Lexicon Pharmaceuticals, Inc. (LXRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Lexicon Pharmaceuticals, Inc. (LXRX) Current Ratio vs. Peers

How is LXRX’s Current Ratio compared to its peers?

Lexicon Pharmaceuticals, Inc.’s Current Ratio is greater than Omeros Corporation (3.03), greater than Bicycle Therapeutics plc (12.66), greater than RAPT Therapeutics, Inc. (12.04), less than Fulcrum Therapeutics, Inc. (34.33), greater than Gossamer Bio, Inc. (2.20), greater than 4D Molecular Therapeutics, Inc. (9.34), greater than ADC Therapeutics S.A. (4.09), greater than Neumora Therapeutics, Inc. Common Stock (5.09), greater than Ocugen, Inc. (1.86), less than Compass Therapeutics, Inc. (19.04),

Build a custom stock screener for Lexicon Pharmaceuticals, Inc. (LXRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lexicon Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lexicon Pharmaceuticals, Inc. (LXRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lexicon Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.